Sign in
4

Changes in Ownership

Mereo BioPharma Group plc Filed Acc 0001193125-26-033754

Options or other derivatives

  • Chief Scientific Officer acquired 331,550 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lewicki John A. · Chief Scientific Officer

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-02-01 Grant or award : show line 1 in the form Share Options (Right to buy) +139,913 139,913 D
2026-02-01 Grant or award : show line 2 in the form Share Options (Right to buy) +46,637 46,637 D
2026-02-01 Grant or award : show line 3 in the form Share Options (Right to buy) +145,000 145,000 D
Loading xslF345X05/ownership.xml…